Here are eight things for spinal surgeons to know for June 2, 2016.
K2M's CASCADIA interbody systems receive FDA clearance
K2M received FDA 510(k) clearances to market its CASCADIA Cervical and CASCADIA AN Lordotic Oblique Interbody Systems featuring Lamellar 3D Titanium Technology. K2M's Lamellar 3D Titanium Technology uses an advanced 3D printing method to create structures that allow for bony integration throughout an implant.
Paradigm Spine pays $585k in False Claims Act settlement; denies allegations
New York-based Paradigm Spine agreed to pay the United States $585,000 to settle False Claims Act allegations, according to the United States Attorney's Office District of Maryland. Paradigm Spine denies all allegations.
44% of female physicians have net worth under $500,000
Twenty-three percent of female physicians have net worth between $500,000 and $999,000 and 2 percent have net worth of more than $5 million, according to Medscape Female Physician Compensation Report 2016.
Medtronic full-year 2016 revenue hits $28.8B; Spine revenue totals $2.9B+
Medtronic has announced financial results for its fourth quarter and full fiscal year 2016, which ended April 29, 2016. The company reported fourth quarter worldwide revenue of $7.57 billion. The restorative therapies group, which includes the spine, neuromodulation, surgical technologies and neurovascular, reported worldwide fourth quarter revenues of $1.88 billion.
Spine fellowship directors rate avoidable, unavoidable spine surgery complications
Researchers surveyed orthopedic spine surgery fellowship directors about spine-related adverse events and hospital-acquired conditions in a new Spine study. Respondents rated the following events as completely avoidable:
- Incompatible blood
- Retained foreign object
- Wrong level surgery
Opioids may exacerbate chronic pain
University of Colorado Boulder researchers studied opioids' impact on chronic pain in lab rats, according to Science News Hub. Following a few days of morphine therapy, the rats experienced continuous aches for many months. The opioids caused the rats' spinal cord glial cells to overreact, which led to spinal cord inflammation.
Aurora Spine completes non-brokered private placement of 2.53M common shares
Aurora Spine completed a non-brokered private placement of common shares. Under the offering, the company issued 2.53 million common shares at a price of $0.15 per share for aggregate gross proceeds of $385,443. Aurora Spine will use the offering's proceeds for general working capital purposes.
The Leading Physicians of the World adds neurosurgeon Dr. Saeed Bajwa
The Leading Physicians of the World welcomed neurosurgeon Saeed Bajwa, MD, of Southern New York NeuroSurgical Group in Johnston City. The group honors physicians across all medical specialties who demonstrate excellence.